Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Curran Terrie received 5,778 Arcutis Biotherapeutics, Inc. shares as an award (Form 4)
Traded Jun 5, 2026 · Filed Jun 9, 2026
On Jun 5, 2026, Curran Terrie (Director) received 5,778 Arcutis Biotherapeutics, Inc. shares as an award, leaving 23,526 shares. Filed Jun 9, 2026 (Form 4).
- Awarded
- 5,778 shares
- Holding after
- 23,526 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Award | 5,778 | 23,526 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Curran Terrie
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Curran Terrie · Aug 28, 2026
- Form 4 · Curran Terrie · Aug 24, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026